79 related articles for article (PubMed ID: 7760880)
41. [Acute myeloid leukemia with complete remission].
BERGSTROM I; LJUNGGREN H
Nord Med; 1950 Sep; 44(37):1482-3. PubMed ID: 14806944
[No Abstract] [Full Text] [Related]
42. Immunotherapy for acute myelogenous leukaemia.
Powles R
Ir J Med Sci; 1974 Jul; 0(0):suppl:10-3. PubMed ID: 4527840
[No Abstract] [Full Text] [Related]
43. Association of social deprivation with survival in younger adult patients with AML: an Alliance study.
Rebechi M; Kohlschmidt J; Mrózek K; Nicolet D; Mims AS; Blachly JS; Orwick S; Larkin KT; Oakes CC; Hantel A; Carroll AJ; Blum WG; Powell BL; Uy GL; Stone RM; Larson RA; Byrd JC; Paskett ED; Plascak JJ; Eisfeld AK
Blood Adv; 2023 Aug; 7(15):4019-4023. PubMed ID: 37196637
[No Abstract] [Full Text] [Related]
44. [The treatment of acute myeloid leudemia].
Manor Y; Ramot B
Harefuah; 1980 Mar; 98(5):227-9. PubMed ID: 6931822
[No Abstract] [Full Text] [Related]
45. Acute non-lymphoblastic leukemias in childhood.
Dole MG; Warrier RP; Yu LC
Indian J Pediatr; 1989; 56(6):683-92. PubMed ID: 2700561
[No Abstract] [Full Text] [Related]
46. SNPing away to individualize induction therapy for acute myelogenous leukemia.
Kaplan JB; Altman JK; Platanias LC
Leuk Lymphoma; 2016; 57(4):742-3. PubMed ID: 26784362
[No Abstract] [Full Text] [Related]
47. Acute myelogenous leukemia and hepatitis.
Cacciola E; Giustolisi R
Ann Intern Med; 1980 Jan; 92(1):127-8. PubMed ID: 6927953
[No Abstract] [Full Text] [Related]
48. Advances in the biology and therapy of acute myelogenous leukemia. Selection of keynote addresses from the Acute Leukemia Forum 2007. March 23, 2007. San Francisco, California, USA.
Best Pract Res Clin Haematol; 2008 Mar; 21(1):1-98. PubMed ID: 18561374
[No Abstract] [Full Text] [Related]
49. [Acute myelogenous leukemia. When the choice is between a good and a bad death].
Hjort PF; Stavem P; Evensen SA
Sykepleien; 1986 Jan; 73(2):23-5, 29. PubMed ID: 3082030
[No Abstract] [Full Text] [Related]
50. The patient who tried to cure his own cancer. Revisiting the story of Morris Abram's leukemia.
Lerner BH
Pharos Alpha Omega Alpha Honor Med Soc; 2007; 70(4):10-3. PubMed ID: 18078148
[No Abstract] [Full Text] [Related]
51. Age, phenotype, and curability in acute myelogenous leukemia.
Arlin Z; Feldman E; Finger L; Mittelman A; Ahmed T
Cancer Invest; 1991; 9(6):655-7. PubMed ID: 1747792
[No Abstract] [Full Text] [Related]
52. Uncertainties in the standard care of acute myelogenous leukemia.
Rowe JM
Leukemia; 2001 Apr; 15(4):677-9. PubMed ID: 11368379
[No Abstract] [Full Text] [Related]
53. Acute myelogenous leukaemia.
Pinto A; Zulian GB; Archimbaud E
Crit Rev Oncol Hematol; 1998 Feb; 27(2):161-4. PubMed ID: 9571323
[No Abstract] [Full Text] [Related]
54. [Current situation and perspective for treatment of acute myelogenous leukemia in adults].
Fukushima T; Ueda T
Gan To Kagaku Ryoho; 1998 Feb; 25(3):295-302. PubMed ID: 9492819
[TBL] [Abstract][Full Text] [Related]
55. Treatment of acute myelogenous leukemia.
Meisenberg B
N Engl J Med; 1995 Jun; 332(25):1718; author reply 1718-9. PubMed ID: 7619165
[No Abstract] [Full Text] [Related]
56. [Indications for allogeneic bone marrow transplantation (BMT) in adult acute myelogenous leukemia: matched-pair analysis in comparison with chemotherapy in patients achieving initial remission].
Sakura T
Rinsho Ketsueki; 2001 May; 42(5):380-4. PubMed ID: 11452455
[No Abstract] [Full Text] [Related]
57. [Bone marrow transplantation in the treatment of acute leukemias].
Moiseev SI; Ganapiev AA; Abdulkadyrov KM
Ter Arkh; 1996; 68(12):8-10. PubMed ID: 9054052
[TBL] [Abstract][Full Text] [Related]
58. Treatment of acute myelogenous leukaemia.
Löwenberg B
J Intern Med Suppl; 1997; 740():17-22. PubMed ID: 9350177
[TBL] [Abstract][Full Text] [Related]
59. Treatment of acute myelogenous leukemia.
Ghaddar H; Anderlini P; Estey E
N Engl J Med; 1995 Jun; 332(25):1717-8; author reply 1718-9. PubMed ID: 7760880
[No Abstract] [Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
